DEEP MEDICINE ACQUISITION CORP. : Shareholder Director Nominations, Other Events (form 8-K) - Marketscreener.com

Item 5.08. Shareholder Director Nominations.

(a) To the grade applicable, the accusation successful Item 8.01 of this Form 8-K is incorporated by notation into this Item 5.08.

On November 18, 2022, Deep Medicine Acquisition Corp. (the "Company") determined that a peculiar gathering of its stockholders volition beryllium held successful lieu of its 2022 Annual Meeting of Stockholders (the "Meeting") connected oregon astir Friday, December 23, 2022. The clip and determination of the Meeting volition beryllium arsenic acceptable distant successful the Company's definitive proxy connection for the Meeting to beryllium filed with the Securities and Exchange Commission (the "SEC"). Pursuant to the Company's bylaws (the "Bylaws"), stockholders seeking to bring concern earlier the Meeting oregon to nominate candidates for predetermination arsenic directors astatine the Meeting indispensable present such proposals oregon nominations to the main enforcement offices of the Company at 595 Madison Avenue, 12th Floor, New York, NY, Attention: Humphrey P. Polanen, Chief Executive Officer, nary aboriginal than December 1, 2022. Any stockholder proposal oregon manager nominations indispensable besides comply with the requirements of Delaware law, the rules and regulations promulgated by the SEC and the Bylaws.

© Edgar Online, root Glimpses